Margreet Lang
Impact in
-
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
-
- Proteoglycans and glycosaminoglycans research
Papers in
-
- Blood Pressure and Hypertension Studies 3
- Heart Rate Variability and Autonomic Control 1
- Surgery 2
- Esophageal Cancer Research and Treatment 1
- Co-authors
- Remco de Bree (3 shared papers)Bernard M. Tijink (2 shared papers)C. René Leemans (2 shared papers)Giuseppe Giaccone (2 shared papers)Jan Buter (2 shared papers)Alexander Staab (2 shared papers)Guus A.M.S. van Dongen (1 shared paper)Steen Neldam (3 shared papers)
- Journals
- Clinical Cancer Research (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Journal of Hypertension (1 paper)Journal of Clinical Hypertension (1 paper)Radiotherapy and Oncology (1 paper)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Margreet Lang
7 papers receiving 331 citations
Peers
Comparison fields: 5 of 46
- Oncology 169
- Cell Biology 78
- Radiology, Nuclear Medicine and Imaging 74
- Immunology and Allergy 16
- Cancer Research 31
Countries citing papers authored by Margreet Lang
This map shows the geographic impact of Margreet Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margreet Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margreet Lang more than expected).
Fields of papers citing papers by Margreet Lang
This network shows the impact of papers produced by Margreet Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margreet Lang. The network helps show where Margreet Lang may publish in the future.
Co-authors
The 23 scholars most cited alongside Margreet Lang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 243 | |
| 2 | Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer. | 2003 | 32 |
| 3 | 2011 | 31 | |
| 4 | 2000 | 26 | |
| 5 | 2012 | 6 | |
| 6 | 2007 | 1 | |
| 7 | 2010 | 1 |
About Margreet Lang
Margreet Lang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Oncology, having authored 7 papers that have together received 340 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (3 papers), Prostate Cancer Treatment and Research (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Cancer Cells and Metastasis (1 paper), Pharmaceutical Economics and Policy (1 paper), Heart Rate Variability and Autonomic Control (1 paper), Pharmaceutical studies and practices (1 paper) and Esophageal Cancer Research and Treatment (1 paper). The work is most often cited by research in Oncology (169 citations), Cell Biology (78 citations), Radiology, Nuclear Medicine and Imaging (74 citations), Immunology and Allergy (16 citations) and Cancer Research (31 citations). Margreet Lang has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Remco de Bree, Bernard M. Tijink, C. René Leemans, Giuseppe Giaccone, Jan Buter, Alexander Staab, Guus A.M.S. van Dongen, Steen Neldam, Russell Jones and J.P. van Brussel. Their work appears in journals such as Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Journal of Hypertension, Journal of Clinical Hypertension and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.